ERBB2 and neoplasm: While not all candidates validated by immunoblotting, we did observe phosphorylation of both ErbB2 and PDGFRβ in at least some of the recurrent tumours, suggesting that RTK signalling was actively occurring (Additional file 6: Figure S6B).